GLP-1 plateaus: what the science says vs. TikTok advice

What did @theejernine actually say?

@theejernine laid out five strategies she used to break a weight-loss plateau while on a GLP-1 medication: eating enough (and slightly more), staying hydrated with electrolytes, moving her body through low-impact activity like walking, rotating injection sites, and using lipo B and lipo C injections. She framed this as personal experience, not medical advice, and explicitly said the lipo B/C tip "might be a little controversial." Credit where it's due: she was upfront about that caveat. The injection site rotation tip is the most specific and least commonly discussed claim here, while the lipo B/C claim is the one that deserves the most scrutiny.

Does the science back this up?

Some of it, yes. The hydration, movement, and caloric intake recommendations are grounded in basic physiology. The injection site rotation claim has a plausible mechanism. The lipo B and lipo C claim is where the evidence gets thin fast.

On caloric intake: a common mistake on GLP-1 medications is eating too little, which can slow resting metabolic rate. Research published by Leibel et al. (1995, New England Journal of Medicine) established that metabolic adaptation occurs with caloric restriction. Eating slightly more to prevent that adaptation is not a wild idea.

On hydration: there is no strong clinical evidence that electrolyte-enhanced water breaks a GLP-1 plateau specifically, but adequate hydration supports general metabolic function. It's reasonable, not transformative.

On injection site rotation: lipohypertrophy, or scar tissue buildup from repeated injections, can impair drug absorption. A 2020 study by Gentile et al. (Diabetes Therapy) found that injection site rotation improved glycemic control in insulin users by reducing absorption variability. The same logic applies to subcutaneous GLP-1 injections, though direct GLP-1-specific studies are limited.

On lipo B and lipo C: these are compounded injectable formulas typically containing B vitamins, methionine, inositol, and choline (MIC). There is no peer-reviewed clinical trial evidence that lipo B or lipo C injections break a GLP-1 weight-loss plateau. Her one-month anecdote is not a controlled experiment.

What did they get right and what did they miss?

She got a lot of the foundational stuff right. "Move your body" instead of "go to the gym" is a meaningful distinction. Adherence to low-impact activity like walking is more sustainable for most people, and research supports that even modest increases in non-exercise activity thermogenesis (NEAT) contribute to weight loss. Pontzer et al. (2016, Current Biology) showed that total daily energy expenditure is influenced significantly by NEAT, not just structured exercise.

The injection site rotation tip is genuinely underappreciated and she deserves credit for raising it. Most GLP-1 users are not told this explicitly by their providers.

Where she goes wrong is the lipo B/lipo C claim. Correlation is not causation. She stalled, added lipo injections, and then reached her goal. That's a personal timeline, not evidence. Lipo injections are not FDA-approved for weight loss, and the evidence base for them is weak at best. Recommending them to 9,300 viewers as a plateau-breaker based on one personal experience is a stretch.

What should you actually know?

Weight-loss plateaus on GLP-1 medications are normal and expected. Your body adapts. That is not a failure of the drug or of you. Before chasing add-on supplements, the more evidence-backed levers are: confirming adequate protein intake (at least 1.2 grams per kilogram of body weight, per current obesity medicine guidelines), checking that injection technique and site rotation are correct, ensuring hydration is adequate, and discussing with your prescriber whether a dose adjustment is appropriate.

If you are considering lipo B or lipo C injections, that is a conversation to have with a licensed provider, not a TikTok checklist item. These are compounded products, and compounded formulations are not equivalent to FDA-approved medications. They carry their own variability in potency and sterility standards.

One more thing: @theejernine noted she "wished she would have done" strength training sooner. That instinct is backed by data. Preserving lean muscle mass during GLP-1-assisted weight loss matters for long-term metabolic health. Resistance training during active weight loss helps protect against muscle loss, which is a documented concern with rapid GLP-1-induced weight reduction (Wilding et al., 2021, New England Journal of Medicine).